Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 35.16m |
Free float | 26.84m |
P/E (TTM) | -- |
Market cap | 90.71m USD |
EPS (TTM) | -0.939 USD |
--
More ▼
Announcements
- FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
- FibroBiologics Engages Southern Star Research as CRO in Australia
- FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
- FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
- FibroBiologics Files 2024 Second Quarter Report
- FibroBiologics to Present at JonesTrading Healthcare Summit 2024
- FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
- FibroBiologics Set to Join Russell 2000® Index
- FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
More ▼